Clinical Trial: Blood and imagE-guided Optimization of Neoadjuvant Therapy in People With Early Stage Triple-negative Breast cancER - the BETTER Trial

U.S., May 29 -- ClinicalTrials.gov registry received information related to the study (NCT07610525) titled 'Blood and imagE-guided Optimization of Neoadjuvant Therapy in People With Early Stage Triple-negative Breast cancER - the BETTER Trial' on May 19.

Brief Summary: To learn whether certain blood and imaging tests can show which people with early-stage TNBC may already have had a complete response to chemotherapy before they go to surgery.

Study Start Date: Nov. 05, 2026

Study Type: INTERVENTIONAL

Condition: Triple Negative Breast Cancer Blood and Image Guided Optimization of Neoadjuvant Therapy Phase 2

Intervention: DRUG: Paclitaxel + Carboplatin

Given by IV

DRUG: Pembrolizumab

Given by IV

Recruitment Status: NOT_YET_RECRUITI...